[1]
D. Malin and P. Ryvkin, “CLINICALLY RELEVANT DRUG INTERACTIONS IN THE TREATMENT OF SECOND-GENERATION ANTIPSYCHOTICS”, СТПР, no. 2, pp. 36–45, June 2021.